SCHEMBL7186260

SCHEMBL7186260

CCOc1c(C=CC(=O)c2ccc(NC)cc2)cc(C(C)(C)C)c(O)c1C(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TNFRSF1A P19438 1/20 0.41
MAOB P27338 8/20 0.41
ABCG2 Q9UNQ0 1/20 0.41
CYP1A1 P04798 3/20 0.40
CYP1B1 Q16678 3/20 0.40
PTPN1 P18031 1/20 0.39
MAOA P21397 1/20 0.39
DPP4 P27487 2/20 0.39
MAPT P10636 2/20 0.39
RAB9A P51151 2/20 0.39
LMNA P02545 1/20 0.39
ATM Q13315 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
NPC1 O15118 1/20 0.39
NPSR1 Q6W5P4 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7186257 1.00 TNFRSF1A (0.41) TNFRSF1AMAOBABCG2CYP1A1CYP1B1
SCHEMBL7182572 0.92 ABCG2 (0.43) TNFRSF1AABCG2CYP1A1CYP1B1PTPN1
SCHEMBL7182567 0.92 ABCG2 (0.43) TNFRSF1AABCG2CYP1A1CYP1B1PTPN1
SCHEMBL7191633 0.89 ABCG2 (0.52) TNFRSF1AMAOBABCG2CYP1A1CYP1B1
SCHEMBL7191637 0.89 ABCG2 (0.52) TNFRSF1AMAOBABCG2CYP1A1CYP1B1
SCHEMBL7804209 0.89 TNFRSF1A (0.46) TNFRSF1AABCG2PTPN1DPP4MAPT
SCHEMBL7804212 0.89 TNFRSF1A (0.46) TNFRSF1AABCG2PTPN1DPP4MAPT
SCHEMBL7186244 0.88 CYP1A1 (0.39) MAOBABCG2CYP1A1CYP1B1PTPN1
SCHEMBL7186242 0.88 CYP1A1 (0.39) MAOBABCG2CYP1A1CYP1B1PTPN1
SCHEMBL7182489 0.88 CTSL (0.45) TNFRSF1AMAOBABCG2CYP1A1CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed